Company profile: Vertellus
1.1 - Company Overview
Company description
- Provider of specialty chemical ingredients for pharmaceuticals, personal care, nutrition, and agriculture, with emphasis on green chemistries. #1 global producer of pyridine, picolines, specialty pyridine derivatives, and DEET. Products include small-molecule APIs; biocompatible polyurethane adhesives/sealants for medical devices; nutraceuticals (Vitamin B3, Zinc, Potassium Chloride); sugar- and amino acid-based surfactants; and silicone-free pigment dispersants for mineral UV filters.
Products and services
- Active Pharmaceutical Ingredients: US-produced small-molecule APIs used in various treatments via oral solid dosage forms and injectables, enabling therapeutics across multiple dosing routes
- Nutraceuticals: Vitamin-based products including Vitamin B3, Zinc, and Potassium Chloride that support bodily functions, delay aging, prevent chronic diseases, and improve health
- Amino Acid-Based Surfactants: Sulfate-free surfactants used in personal and home care for gentle and effective cleaning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vertellus
Pharsight
HQ: United States
Website
- Description: Provider of software and scientific consulting services to pharmaceutical and biotechnology companies in the United States, Europe, and internationally, offering products including Phoenix WinNonlin and WinNonMix for statistical analysis and mathematical modeling of pharmacokinetic (PK)/pharmacodynamic data, and Trial Simulator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharsight company profile →
HistoTox Labs
HQ: United States
Website
- Description: Provider of histology and histopathology services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HistoTox Labs company profile →
Defence Therapeutics
HQ: Canada
Website
- Description: Provider of biopharmaceutical innovations leveraging Accum™ technology, a drug delivery platform that enhances delivery of therapeutic agents to target cells to improve efficacy for cancer and infectious diseases. Offerings include cancer therapeutics, vaccine development for infectious diseases and cancers, antibody-drug conjugates, AccuTOX, and the ARM-002 anti-cancer vaccine shown effective in pre-clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Defence Therapeutics company profile →
Selcia
HQ: United States
Website
- Description: Provider of integrated drug discovery services and high quality 14C radiolabelled compounds to pharma, biotechnology companies and academia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Selcia company profile →
Hydra Biosciences
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development leveraging novel ion channels to develop drugs for pain, inflammation, cardiovascular and other diseases, based in Cambridge, Massachusetts, utilizing proprietary high-throughput screening platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hydra Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vertellus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vertellus
2.2 - Growth funds investing in similar companies to Vertellus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vertellus
4.2 - Public trading comparable groups for Vertellus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →